Studies on spiro[4.5]decanone prolyl hydroxylase domain inhibitors
The 2-oxoglutarate (2OG) dependent hypoxia inducible factor (HIF) prolyl hydroxylases (PHDs) are targets for treatment of anaemia and other ischaemia related diseases. PHD inhibitors are in clinical trials; however, the number of reported templates for PHD inhibition is limited. We report structure–...
Main Authors: | Holt-Martyn, J, Tumber, A, Rahman, M, Lippl, K, Figg, W, McDonough, M, Chowdhury, R, Schofield, C |
---|---|
פורמט: | Journal article |
יצא לאור: |
Royal Society of Chemistry
2019
|
פריטים דומים
-
Structure–activity relationship and crystallographic studies on 4-hydroxypyrimidine HIF prolyl hydroxylase domain inhibitors
מאת: Holt-Martyn, JP, et al.
יצא לאור: (2019) -
Structural basis of prolyl hydroxylase domain inhibition by Molidustat
מאת: Figg, WD, et al.
יצא לאור: (2021) -
Structural basis for binding of the renal carcinoma target hypoxia-inducible factor 2α to prolyl hydroxylase domain 2
מאת: Figg, WD, et al.
יצא לאור: (2023) -
Novel and selective small molecule inhibitors and activators for the prolyl hydroxylase domain enzyme
מאת: Holt-Martyn, J
יצא לאור: (2018) -
2-Oxoglutarate analogue inhibitors of prolyl hydroxylase domain 2.
מאת: Mecinović, J, et al.
יצא לאור: (2009)